BASF SEBASF launches a new bio-identical collagen ingredient for personal care, expanding its product portfolio and potential sales.

Bota Biosciences and BASF have jointly launched SkinNexus™ Collag3n, a 100% human-identical recombinant Collagen III fragment for the personal care market. The ingredient was developed using Bota's Physical AI-driven biofoundry and BASF's cosmetic actives technology, screening over 2,000 collagen fragments. In 3D dermis models, it boosted Collagen I by 48%, Collagen III by 82%, and Collagen V by 71%, and clinical trials on women aged 53 to 70 showed improvements in sagging and wrinkles after four weeks, outperforming a collagen benchmark used at ten times the concentration. The product debuted at in-cosmetics Global in April 2026 and is commercialized by BASF.
BASF SEBASF launches a new bio-identical collagen ingredient for personal care, expanding its product portfolio and potential sales.
Bota Biosciences' Physical AI-driven biofoundry developed a novel collagen ingredient, demonstrating technological capability and potential licensing revenue.